China Urges APEC Cooperation as Trade Minister Steps In for Commerce Minister on Urgent Business Venture Capital Shifts Focus to LowMargin Unglamorous Industries Inflations Broadening Beyond Oil and Iran These Sectors Show Reaccelerating Price Pressures Bitcoin Dips Below 76000 as Liquidations and Rate Volatility Fuel Weekly Decline Social Media Risks for Youth Compared to Smoking by UK Doctors Potential Impact on Tech Sector Michael Saylor Highlights Tokenization as a Free Market for Yield and Credit USEG Q1 2026 Earnings EPS Falls Short of Estimates Amid Challenging Conditions Eagle Point Income Company Inc EIC Q4 2025 Earnings Slight EPS Miss but Stock Holds Steady PSBD Q1 2026 Earnings Significant EPS Miss Driven by Unrealized Losses CMPS Q1 2026 Earnings Narrower Loss Drives Positive Investor Sentiment Agilysys Inc Q1 2026 Earnings EPS Surges Past Consensus by 244 Stock Edges Higher NWN Q1 2026 Earnings EPS Misses Estimates Amid Operational Headwinds Sezzle Inc SEZL Slides 25 as Fintech Sector Headwinds Weigh on Sentiment Oracle ORCL Gains 23 as Cloud Momentum Drives Price Above Key Support CollPlant Biotechnologies CLGN Slides 667 as Selling Pressure Mounts BDCIW Warrants Hold Steady at 045 as Support and Resistance Levels Define Trading Range Champion Homes Inc SKY Rallies 325 as Housing Sector Sentiment Improves Dow Leads Wall Street Higher as Healthcare and Tech Stocks Rally ClearOne Inc CLRO Q2 2018 Earnings EPS Surprise Drives Stock Gain Amid Revenue Silence Cheche Group Inc CCG Tests Key Resistance After 35 Gain Aspen Aerogels ASPN Q1 2026 Earnings EPS Misses Estimates as Aerogel Leader Posts WiderThanExpected Loss Fluent Inc FLNT Q1 2026 Earnings EPS Beats Estimates Narrowly as Revenue Remains Unreported DBRG Q1 2026 Earnings EPS Misses Estimates by 39 Amid Challenging Market Corvus Pharmaceuticals CRVS Q1 2026 Earnings RD Pipeline Progress Amid Slight EPS Miss SRTA Q1 2026 Earnings Surprise Profitability Despite No Reported Revenue Serve Robotics SERV Q1 2026 Earnings WiderThanExpected Losses Highlight Cost Pressures NervGen Pharma Q3 2025 Earnings Narrowed Loss Meets Estimates But Stock Plunges 43